Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 4036 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Threshold completes enrollment in prostate trial

The phase III trial, being conducted in Europe and Canada, is investigating the safety and efficacy of TH-070 in patients with benign prostatic hyperplasia (BPH). Approximately 500 patients

Vertex begins new study of cancer drug

Vertex has earned a $10 million milestone payment from Merck & Co. as a result of this step forward in the drug’s development. The companies entered a global

Positive results for Bioenvision’s Evoltra

The study used a combination of Evoltra (clofarabine) with the traditional chemotherapy agent daunorubicin. Results showed an overall response had been achieved in 92% of patients over 60

Union slams Medco staff lockout

Jack Hammond, USW District 12 international representative, said the National Labor Relations Board (NLRB) had already issued a complaint against Medco for its illegal interference with employees’ solidarity